Advantage DCT tissue machine from Valmet Oyj - a quiet longrunner in tissue production

Reviewed: ad hoc news Classics & Longseller desk. Edited and checked on 2026-06-28, 06:58. Details in the imprint.

The Advantage DCT tissue machine from Valmet Oyj sits in a steaming hall, its steel frames humming while a wide ribbon of soft tissue glides over the Yankee cylinder and dries with a faint crackle. Operators feel the heat on their cheeks as they walk past the hood.

How Advantage DCT is built

Advantage DCT is Valmet's conventional tissue machine concept, combining a headbox, forming section, press, large Yankee cylinder and high-efficiency hood into a compact line for toilet and towel grades. Compared with older machines, it targets higher dryness out of the press and better overall energy balance.

The design allows widths around the 5.6-meter class and speeds that, in reference plants, reach well above 1,800 meters per minute, giving producers tight control over basis weight and crepe for premium and standard products alike. The focus is on stable runnability with as few unscheduled stops as possible.

How it feels in daily operation

Walk with a shift leader past an Advantage DCT and you notice the tidy layout: access platforms are straightforward, cable routes are clean, and most inspection points are reachable without acrobatics. That makes daily checks smoother when the line runs at full speed.

On the operator screen, the logic is practical rather than flashy, with trends for moisture, hood temperature and steam pressures laid out so staff can spot drift quickly. During grade changes, crews appreciate that the concept is consistent, so recipes are adjusted, not reinvented, which keeps tension on the wire and felt manageable.

Energy and fiber efficiency

In tissue, energy is a big bill, and Advantage DCT aims at a consistent balance between thermal and electrical load by pairing the Yankee and hood with optimized heat recovery. Mills that retrofit modern hoods on this platform report more controlled gas or steam consumption versus legacy lines.

Fiber efficiency matters too, and the machine's wet-end concept is configured so furnish changes between virgin pulp and recycled fiber can be made with predictable impact on strength and softness. When a mill chases softer feel for bathroom tissue, the creping and pressing setup on Advantage DCT gives it a clear adjustment toolbox.

What customers and Valmet say

Valmet CEO Pasi Laine has often pointed to tissue technologies, including Advantage DCT, as part of the company's stable base in paper-making equipment when speaking with analysts. In practice, the concept has been installed in multiple regions, turning it into a familiar reference in project negotiations.

Process engineers at customer mills describe the machine as robust rather than exotic. They highlight that spare parts and service procedures follow Valmet's broader tissue portfolio, so maintenance teams are not forced into unusual tooling or training, which reduces friction when the line needs planned overhauls.

Where Advantage DCT falls short

Advantage DCT is a conventional tissue machine, which means it does not aim for the dryness or bulk levels associated with newer hybrid or TAD-type technologies. Producers looking for extra-soft premium tissue often combine DCT lines with converting concepts rather than expecting the machine alone to deliver a step change.

Space requirements can be a constraint in older mills. The Yankee cylinder, hood and auxiliaries demand a clear hall layout, and retrofits in cramped buildings can become tricky, pushing some projects toward greenfield sites instead of brownfield upgrades.

Company context and shares

Valmet has built its identity around paper, board and tissue machinery, but also automation and services, with Advantage DCT acting as one of the longrunning tissue platforms that keep its machines in daily use at many mills. Overall, this installed base underpins service and spare-part revenues tied to tissue.

Net-net, the Advantage DCT family helps anchor Valmet's presence in tissue, while investors follow how many such lines appear in the order pipeline. Valmet shares (ISIN FI4000074984) trade primarily on Nasdaq Helsinki in euros, giving Nordic investors a direct read on the company's valuation.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.